PEAK6 Investments’s enVVeno Medical NVNO Stock Holding History

PEAK6 Investments’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-53	Closed	-$12K	–	6375
2022 Q1	$12K	Buy	53 +2	+4%	+$388	﹤0.01%	4809
2021 Q4	$12K	Buy	+51	New	+$14.4K	﹤0.01%	4875

Other funds holding NVNO

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $127M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AMCA

Arthur M. Cohen & Associates Northbrook, Illinois $563M AUM 20.97% 1-Year Est. Return

PEAK6 Investments's NVNO Position: Q2 2022 in Review

PEAK6 Investments sold out of enVVeno Medical (NVNO) in Q2 2022, closing a stake of 53 shares — an estimated $12K sold.

PEAK6 Investments first reported a position in NVNO in Q4 2021 and held it in 2 quarters. The position peaked at $12K in Q1 2022. 21 funds tracked by Wall St. Rank hold NVNO as of Q2 2022.

PEAK6 Investments reported no remaining enVVeno Medical position as of Q2 2022 after selling out during the quarter.
PEAK6 Investments sold 53 enVVeno Medical shares in Q2 2022, an estimated $12K.
PEAK6 Investments first reported a position in enVVeno Medical in Q4 2021 and held it in 2 quarters.
PEAK6 Investments's enVVeno Medical position peaked at $12K in Q1 2022.
21 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2022.

Based on PEAK6 Investments's 13F filing for Q2 2022, filed 12 Aug 2022.